Loyola University Chicago
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Loyola University Chicago sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Loyola University Chicago: 4 sponsored US clinical trials, none currently recruiting.
Loyola University Chicago sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Spina Bifida, with 1 trials.
Upper-quartile sponsor footprint
Loyola University Chicago sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Psychosocial Adjustment of Adolescents With Spina Bifida
NCT00891891
Afghan Evacuee Resettlement for Stronger Communities (AER)
NCT06786741
Supporting Refugee and Immigrant Youth's Mental Health
NCT05208359
Black Men Evolving Behavioral HIV Prevention Intervention for Black MSM
NCT01722838
Therapeutic Areas
How the Loyola University Chicago archive is shaped
4 indexed studies, none listed as recruiting (0% open); 3 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Spina Bifida (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Loyola University Chicago: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Loyola University Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Loyola University Chicago page
4 registered trials is a research-attention snapshot, not an endorsement of Loyola University Chicago or any single study.
- None of Loyola University Chicago's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Spina Bifida is the condition Loyola University Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spina Bifida trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Loyola University Chicago pipeline card: 4 registered trials from official public datasets.Report a data error.